King-Jones Heidy 内部人交易：近期 SEC Form 4 交易
过去 18 个月，King-Jones Heidy（CIK 1794898）在 1 家公司共报告 13 笔 SEC Form 4 内部人交易（最近一笔 2026-10-02）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Legal Officer and Corporate Secretary | 卖出 | 400 | $35,696 |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Legal Officer and Corporate Secretary | 卖出 | 16,605 | $1.5M |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Legal Officer and Corporate Secretary | 卖出 | 7,228 | $660,278 |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Legal Officer and Corporate Secretary | 卖出 | 2,100 | $194,670 |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Legal Officer and Corporate Secretary | 卖出 | 2,600 | $242,996 |
| 2026-10-02 | Spyre Therapeutics, Inc. (SYRE) | Chief Legal Officer and Corporate Secretary | 买入 | 28,933 | $419,528 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | See Remarks | 卖出 | 6,206 | $547,183 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | See Remarks | 买入 | 27,999 | $405,986 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | See Remarks | 卖出 | 4,845 | $418,608 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | See Remarks | 卖出 | 16,548 | $1.4M |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | See Remarks | 卖出 | 400 | $35,752 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | See Remarks | 买入 | 400 | $5,800 |
| 2026-09-03 | Spyre Therapeutics, Inc. (SYRE) | See Remarks | 卖出 | 400 | $36,000 |
来源：SEC Form 4 申报文件 · 截至 2026-10-02